132 related articles for article (PubMed ID: 38261438)
1. Oral glutamine: Is there a role in the amelioration of radiation-induced mucositis? A prospective case-control study at a tertiary care centre in North India.
Fatima K; Andleeb A; Nasreen S; Sofi MA; Najmi AM; Qadri SK; Ryhan R; Roohi S; Afroz F; Khan NA
J Cancer Res Ther; 2024 Jan; ():. PubMed ID: 38261438
[TBL] [Abstract][Full Text] [Related]
2. Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: A prospective randomized study.
Chattopadhyay S; Saha A; Azam M; Mukherjee A; Sur PK
South Asian J Cancer; 2014 Jan; 3(1):8-12. PubMed ID: 24665438
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Controlled Trial to Evaluate the Role and Efficacy of Oral Glutamine in the Treatment of Chemo-radiotherapy-induced Oral Mucositis and Dysphagia in Patients with Oropharynx and Larynx Carcinoma.
Pathak S; Soni TP; Sharma LM; Patni N; Gupta AK
Cureus; 2019 Jun; 11(6):e4855. PubMed ID: 31410338
[TBL] [Abstract][Full Text] [Related]
4. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial.
Huang EY; Leung SW; Wang CJ; Chen HC; Sun LM; Fang FM; Yeh SA; Hsu HC; Hsiung CY
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):535-9. PubMed ID: 10701731
[TBL] [Abstract][Full Text] [Related]
5. Oral Glutamine May Have No Clinical Benefits to Prevent Radiation-Induced Oral Mucositis in Adult Patients With Head and Neck Cancer: A Meta-Analysis of Randomized Controlled Trials.
Shuai T; Tian X; Xu LL; Chen WQ; Pi YP; Zhang L; Wan QQ; Li XE
Front Nutr; 2020; 7():49. PubMed ID: 32363198
[No Abstract] [Full Text] [Related]
6. Double-blind randomized study of oral glutamine on the management of radio/chemotherapy-induced mucositis and dermatitis in head and neck cancer.
Lopez-Vaquero D; Gutierrez-Bayard L; Rodriguez-Ruiz JA; Saldaña-Valderas M; Infante-Cossio P
Mol Clin Oncol; 2017 Jun; 6(6):931-936. PubMed ID: 28588793
[TBL] [Abstract][Full Text] [Related]
7. Management of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine.
Pattanayak L; Panda N; Dash MK; Mohanty S; Samantaray S
J Glob Oncol; 2016 Aug; 2(4):200-206. PubMed ID: 28717702
[TBL] [Abstract][Full Text] [Related]
8. A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients.
Taylor JK; Mady LJ; Baddour K; Iheagwara UK; Zhai S; Ohr JP; Zandberg DP; Gorantla VC; Ferris RL; Kim S; Duvvuri U; Kubik MW; Sridharan S; Johnson JT; Holeva KD; Quinn AE; Clump DA
World J Otorhinolaryngol Head Neck Surg; 2022 Dec; 8(4):345-354. PubMed ID: 36474663
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.
Huang CJ; Huang MY; Fang PT; Chen F; Wang YT; Chen CH; Yuan SS; Huang CM; Luo KH; Chuang HY; Wang YY; Lee HH
Am J Clin Nutr; 2019 Mar; 109(3):606-614. PubMed ID: 30753262
[TBL] [Abstract][Full Text] [Related]
10. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
[TBL] [Abstract][Full Text] [Related]
11. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
12. Phase IV study on the use of benzydamine mouthwash in radiation-induced oral mucositis in patients with head and neck cancer.
Bossi P; Tellone V; Di Loreto G; Fioravanti S; Salvatori E; Comandini A
Front Oncol; 2024; 14():1345129. PubMed ID: 38469245
[TBL] [Abstract][Full Text] [Related]
13. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
[TBL] [Abstract][Full Text] [Related]
14. Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer.
Iovoli AJ; Turecki L; Qiu ML; Khan M; Smith K; Yu H; Ma SJ; Farrugia MK; Singh AK
JAMA Netw Open; 2023 Oct; 6(10):e2337265. PubMed ID: 37819659
[TBL] [Abstract][Full Text] [Related]
15. Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: Systematic review and meta-analysis of controlled trials.
Alsubaie HM; Alsini AY; Alsubaie KM; Abu-Zaid A; Alzahrani FR; Sayed S; Pathak AK; Alqahtani KH
Head Neck; 2021 Oct; 43(10):3199-3213. PubMed ID: 34240498
[TBL] [Abstract][Full Text] [Related]
16. The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors.
Liu M; An R; Wu Z; Dai L; Zeng Q; Chen W
Ear Nose Throat J; 2024 Feb; ():1455613241228211. PubMed ID: 38334289
[TBL] [Abstract][Full Text] [Related]
17. Pain management in patients undergoing radiation therapy for head and neck cancer - a descriptive study.
Schaller AKCS; Peterson A; Bäckryd E
Scand J Pain; 2021 Apr; 21(2):256-265. PubMed ID: 34387952
[TBL] [Abstract][Full Text] [Related]
18. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of glutamine in the prevention of oral mucositis and acute radiation-induced esophagitis: a retrospective study.
Vidal-Casariego A; Calleja-Fernández A; Ballesteros-Pomar MD; Cano-Rodríguez I
Nutr Cancer; 2013; 65(3):424-9. PubMed ID: 23530642
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
